Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) Operating Expenses (2020 - 2025)

Historic Operating Expenses for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • IM Cannabis' Operating Expenses fell 2566.91% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 6216.35%. This contributed to the annual value of $2.4 million for FY2024, which is 8594.36% down from last year.
  • Latest data reveals that IM Cannabis reported Operating Expenses of $2.2 million as of Q3 2025, which was down 2566.91% from $2.3 million recorded in Q1 2025.
  • In the past 5 years, IM Cannabis' Operating Expenses ranged from a high of $9.8 million in Q4 2022 and a low of -$13891.7 during Q2 2024
  • Moreover, its 5-year median value for Operating Expenses was $5.1 million (2021), whereas its average is $4.9 million.
  • In the last 5 years, IM Cannabis' Operating Expenses skyrocketed by 14358.0% in 2021 and then plummeted by 10035.83% in 2024.
  • IM Cannabis' Operating Expenses (Quarter) stood at $7.7 million in 2021, then increased by 27.18% to $9.8 million in 2022, then plummeted by 55.02% to $4.4 million in 2023, then plummeted by 91.97% to $354345.3 in 2024, then soared by 530.62% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.3 million for Q1 2025, and $354345.3 during Q4 2024.